Titan Biotech LimitedBSE: TITANBIO

Board Meeting Intimation for Approval Of The Audited Financial Results (Standalone & Consolidated) Of The Company For The Quarter And Year Ended March 31, 2026 And To Recommend Dividend, If Any, On The Equity Shares Of The Company For The Financial

· Issued by Titan Biotech Limited via BSE India

Filed with BSE ·

On 6ix: 6ix.com/news/board-meeting-intimation-for-approval-of-the-audited-financial-results-standalone-and-consolidated-of-the-company-for-the-quarter-and-year-ended-march-31-2026-and-to-recommend-dividend-if-any-on-the-equity-shares-of-the-company-for-the-financial

Titan Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and approve the audited financial results (standalone and consolidated) and to recommend dividend, if any.

View Attachment

6ix hasn’t read this filing yet.

View original source (BSE India)Titan Biotech Limited on 6ix

Story so far

Earlier from Titan Biotech

Later from Titan Biotech

All Titan Biotech news releases